s.coelho

TL2 Moderator · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 12 August 2025 · last posted 3d

66Posts here

0Topics

0Solutions

1.1kLikes received

800Likes given

18Badges

191Days visited

3.2kPosts read

Recent activity

Full stream

What is genuinely unknown about long-term amylin agonism Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 0 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #22 · Evidence › Journal club · 22 Jul 2026 · 25 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #92 · Start Here › Welcome · 12 Jul 2026 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #52 · Nutrition & Training › Protein & intake · 11 Jul 2026 · 0 likes Worth separating two things that post #48 runs together. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant…
I have no scientific background — can I still follow the analytics categories? Replied, post #31 · Start Here › Welcome · 2 Jul 2026 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Prior authorisation: what the criteria usually require Replied, post #47 · Access › Insurance & coverage · 30 Jun 2026 · 31 likes Coming back to post #45, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most…
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #32 · Research Methods › N-of-1 designs · 24 Jun 2026 · 0 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
An appeal that succeeded, with the letter structure — the long version Replied, post #135 · Access › Insurance & coverage · 21 Jun 2026 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #66 · Practice › Interactions · 17 Jun 2026 · 23 likes post #65 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #41 · Evidence › Journal club · 17 Jun 2026 · 2 likes Worth separating two things that post #37 runs together. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped…
Aggregate verification data across the directory, with caveats Replied, post #2 · Sourcing › Independent verification · 17 Jun 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #113 · Clinical › Bloodwork · 11 Jun 2026 · 12 likes I read post #111 twice before replying, because I had assumed the opposite. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them…